Overview

Ovarian Hyperstimulation Syndrome Prevention

Status:
RECRUITING
Trial end date:
2025-07-30
Target enrollment:
Participant gender:
Summary
Ovarian hyperstimulation is a very hazardous complication of ICSI
Phase:
NA
Details
Lead Sponsor:
Aljazeera Hospital
Treatments:
Hydroxychloroquine